Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Santen and twoXAR Announce Strategic Research Collaboration to Discover New Glaucoma Treatments

Friday, February 24, 2017

Santen Inc the US subsidiary of Santen Pharmaceutical Co Ltd the specialty ophthalmology company headquartered in Osaka Japan and twoXAR Inc an artificial intelligencedriven biopharmaceutical company today announced that the two companies have entere...

PPD Expands Nephrology Capabilities Through Collaboration with Frenova

Thursday, February 23, 2017

Pharmaceutical Product Development LLC PPD a leading global contract research organization CRO today announced that it has entered into a collaboration with Frenova Renal Research a leading drug and medical device contract clinical development servic...

Soligenix Receives European Patent for Formulation of Synthetic Hypericin to Treat Psoriasis

Thursday, February 23, 2017

Soligenix Inc a latestage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need announced today that its proprietary formulation of synthetic hypericin has been grante...

FDA rejects Amphastar's nasal opioid overdose treatment

Wednesday, February 22, 2017

Amphastar Pharmaceuticals Inc said on Tuesday that the US Food and Drug Administration had rejected its application to market an intranasal version of the emergency opioidoverdose treatment naloxone The abuse of opioids a class of drugs that incl...

AMRI Entered into an Agreement with Ferrer and Accord Healthcare

Wednesday, February 22, 2017

AMRI announced that it has entered into an agreement with the pharmaceutical group Ferrer and Accord Healthcare Inc Accord Healthcare to jointly develop and manufacture an undisclosed complex parenteral drug product for registration and subsequent co...

Valeant Pharmaceuticals and EyeGate Enter into Licensing Agreement for EGP-437 Combination Product

Wednesday, February 22, 2017

Valeant Pharmaceuticals International Inc and EyeGate Pharmaceuticals Inc a specialty pharmaceutical company that focuses on developing and commercializing products for treating diseases and disorders of the eye today announced that they have entered...

Xbrane Biopharma obtains GMP certification for Spherotide production facility

Tuesday, February 21, 2017

Xbrane Biopharma has been granted GMP Good Manufacturing Practice certification for its Spherotide production facility by AIFA the Italian Medicines Agency The GMP certification follows an inspection by AIFA where the production facility was found to...

ICON Selected by the FDA to Validate Patient-Reported Outcome Endpoints for Antibacterial Drug Trials

Tuesday, February 21, 2017

ICON plc a global provider of drug development solutions and services to the pharmaceutical biotechnology and medical device industries today announced that it has been awarded a project by the US Food Drug Administration FDA to validate three Patie...

CTT Pharmaceutical Holdings and CanniMed Therapeutics Inc. Complete Exclusive Canadian Licensing Agreement

Monday, February 20, 2017

Today CanniMed Therapeutics Inc and CTT Pharmaceutical Holdings Inchave entered into a definitive contractual relationship for the licensing of CTTs Orally Dissolvable Thin Film ODF Wafer technology This industryfirst collaboration includes the li...

Immune Pharmaceuticals Announces the launch of REMAIN™

Monday, February 20, 2017

Immune Pharmaceuticals Inc will announce on Monday February th at the Acute Leukemia XVI symposium in Munich Germany that it will be launching REMAIN an international Overall Survival clinical study with the combination of Ceplene the Companys flags...